TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis

Clinical trial NCT06818058 · RECRUITING

Trial details

NCT number: NCT06818058
Sponsor: Tarian Pharma
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

EGFR Inhibitor-associated Rash

Start date: 2025-01-20
Primary completion: 2026-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.